TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Patients Who Required Additional Analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Romantic Relationship Adjustment - Conflict Resolution
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coparenting Adjustment - Communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Negative viral detection in nose swabs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in serum total testosterone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of device related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of individuals who consent to the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of sessions that each consented patient attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of subjects with Adverse Events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of clinical laboratory assessments as a measure of safety and tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of vital signs as a measure of safety and tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: Electrocardiogram (ECG) assessment as a measure of safety and tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: Primary angiographic late loss in the stent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart failure hospitalisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Donor recovery evaluated by physical fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Difference of CD41a and CD31 positive microparticles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Residual shunt rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Minimum effective light dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee and Osteoarthritis Outcome Scores (KOOS) activity subscale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: renal function (serum creatinine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in clinical significant depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pharmacokinetic parameters of fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transferrin saturation (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Inulin clearance performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: MDRD performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Latency period of corneal reflex loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum tolerated dose of Lenvatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute healthcare utilization rates
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage of Participants With ACR20 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean time reaction to the perturbation with the feedback
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved cosmesis
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ventricular tachycardia recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficiency of interferon in Myelofibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Detection of tumor specific DNA in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum blood concentration level of DEX - Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The amount of time that a DEX is present at the maximum concentration - Tmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve for DEX concentration levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asynchronies detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: worst pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Respiratory Incidences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Glycoprotein IIb/IIIa activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Computerized Functional Assessment Scale (CFAS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: No Practice Effect (NPE) Cognitive Battery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Fat distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change From Baseline in Mean Average Score of NRQLQ
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgical satisfaction about visibility of operative field
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Seizure Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Seizure Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to Occurrence of Any Recurrence of Disease
Endpoint domain: Mortality/survival
Primary endpoint: Psychological state change on the Global Severity Index (GSI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hospital-Acquired Infections (HAI) incidence density
Endpoint domain: Adverse events/effects
Primary endpoint: sensitivity and specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total and segmental gastrointestinal transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Abnormal sleep pattern
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Adverse Drug Events
Endpoint domain: Adverse events/effects
Primary endpoint: QTcF intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Metabolic Equivalent of Task (MET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Time <70 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Time >180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: changes in AAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pathologic complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Isokinetic strength of foot and ankle muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in serum levels of CTX-I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of ABT-888
Endpoint domain: Adverse events/effects
Primary endpoint: Dose Limiting Toxicities (DLT) of ABT-888
Endpoint domain: Adverse events/effects
Primary endpoint: alpha-SMA messenger RNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital admission status
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Hospital discharge status/survival at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Change in Pain measured on the Visual Analogue Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Fatal/Life-threatening Bleedings
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Bleeding Events (Major Bleedings)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Major Cardiovascular Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Impact of radiosurgery on quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage change in urinary protein to creatinine ratio (UPCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Improvement in GERD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to Progression of Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longitudinal changes of interleukin-6 (IL-6) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Longitudinal changes of interleukin-8 (IL-8) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Longitudinal changes of interleukin-10 (IL-10) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Longitudinal changes of interferon-gamma (IFN-γ) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Longitudinal changes of soluble TLR4 (sTLR4) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of particles cleared from the lung
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Estimate of small airway clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: AUC 0-24h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone metabolism biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG sleepiness at the wheel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Western Aphasia Battery-Revised Aphasia Quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Visual Regions of Interest Activation intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Connectivity Indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stability of Joint Position Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Economy of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Late Swing Ankle Plantar Flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Late Swing Ankle Dorsiflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change From Baseline Score in the Panic Disorder Severity Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline Score in the Anxiety Sensitivity Index-3
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HCC screening rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Development of NEC
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in Pulmonary Artery Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Subject incidence of treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with change from baseline in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in electrocardiograms (ECGs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neutrophil Extracellular Traps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Upper Extremity Motor Score Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum β-D-glucan kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titers (GMTs) to HPV Types 16 and 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Free recalls of the FCSRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: acute symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changed inhibition levels in the pre-SMA area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: changed inhibition levels in the rIFG area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of stroke volume variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of pulse pressure variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in QTcF from baseline to Day 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Child Behavior Checklist
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child Global Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Interview for Antisocial Behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change From Baseline in Overall Conjunctival Hyperemia Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of participants who deliver by normal delivery
Endpoint domain: Mortality/survival
Primary endpoint: Accrual Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: increase in ventilatory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 1-year Survival of dialysis patients
Endpoint domain: Mortality/survival
Primary endpoint: Phenotypic analysis of immune cell populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Phenotypic analysis of nervous cell populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Metabolic changes of the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Structural changes of the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ulnar nerve surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in muscle protein synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Patient-reported Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in pulmonary function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Health related-quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Heath care utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean serum progesterone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in symptoms of PTSD
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blood Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of molar protraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the level of Interleukin1-β
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average Daily Frequency of Moderate to Severe Hot Flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Daily Severity Score of Moderate to Severe Hot Flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Injury Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distress Tolerance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SERT uptake ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hot flash composite score (HFCS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Immune protective effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Delayed fracture healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of transcutaneous pCO2 per change of body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of respiratory rate per change of body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of transcutaneous pCO2 per change of respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Change From Baseline in the Total Nasal Symptom Score (TNSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in the Peak Nasal Inspiratory Flow (PNIF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average difference in total score of Doctor's Opinions on Collaboration (DOC)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Average difference in total score of Modified Spinal Cord Injury Secondary Conditions Scale (SCI-SCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction or Elimination of Skin Blistering
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Normal values of near infrared spectroscopy (NIRS) reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Subjects Reporting at Least 50% Overall Pain Relief
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Plasma budesonide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Skeletal muscle PGC-1alpha gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mitochondrial gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of use of surgical treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Edmonton Symptom Assessment Scale (ESAS-FS) in Acute Inpatient Rehabilitation Unit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Edmonton Symptom Assessment Scale (ESAS-FS) as an Outpatient
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Reported Outcomes Measurement Information System (PROMIS) in Acute Inpatient Rehabilitation Unit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Reported Outcomes Measurement Information System (PROMIS) as an Outpatient
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: State Trait Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SF-36 Health Survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rescue Morphine Requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidents of child maltreatment
Endpoint domain: Adverse events/effects
Primary endpoint: Change in physical activity from baseline to 8-months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Numeric Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of hypoglycemic episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Phase I Participants With Dose-Limiting Toxicity Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With One or More Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Blood pressure by home measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with demonstrated healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incident adverse drug reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Latency to Persistent Sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Total Motile Sperm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes